Last reviewed · How we verify
epirubicin+cisplatin+capecitabine
epirubicin+cisplatin+capecitabine is a Small molecule drug developed by Dutch Colorectal Cancer Group. It is currently in Phase 3 development.
At a glance
| Generic name | epirubicin+cisplatin+capecitabine |
|---|---|
| Sponsor | Dutch Colorectal Cancer Group |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma (PHASE2, PHASE3)
- SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (PHASE2)
- Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma (PHASE2, PHASE3)
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) (PHASE3)
- Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (PHASE3)
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (PHASE2)
- Observational Study of Perioperative Chemotherapy in Gastric Cancer
- Breast Cancer Treatment Based on Organ-like Culture
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- epirubicin+cisplatin+capecitabine CI brief — competitive landscape report
- epirubicin+cisplatin+capecitabine updates RSS · CI watch RSS
- Dutch Colorectal Cancer Group portfolio CI
Frequently asked questions about epirubicin+cisplatin+capecitabine
What is epirubicin+cisplatin+capecitabine?
epirubicin+cisplatin+capecitabine is a Small molecule drug developed by Dutch Colorectal Cancer Group.
Who makes epirubicin+cisplatin+capecitabine?
epirubicin+cisplatin+capecitabine is developed by Dutch Colorectal Cancer Group (see full Dutch Colorectal Cancer Group pipeline at /company/dutch-colorectal-cancer-group).
What development phase is epirubicin+cisplatin+capecitabine in?
epirubicin+cisplatin+capecitabine is in Phase 3.
Related
- Manufacturer: Dutch Colorectal Cancer Group — full pipeline